Skip to main content

Federal Practitioner

FULL MENU Close Menu

Federal Practitioner

CE/CME
Cardiology
Diabetes
Federal News
Journal
Mental Health
Oncology
Pharmacology
Women's Health

Pharmacology

Finasteride and Prostate Cancer Development

Fed Pract. 2003 September;20(9):61

Oncology

This Publication

Advertise
Digital Edition/App
Digital Supplements
Contact Us
Corporate Management
Editorial Advisory Association
Multimedia
Editorial Policies
Submission Guidelines
Subscribe to Federal Practitioner

Facebook
Twitter

Top Sections

Best Practices
Government and Regulations
Original Research

Editorial Policy

Medscape Customer Support

Frequently Asked Questions

Advertise with MDedge

See more with MDedge! See our Other Publications

MDedge: Keeping You Informed. Saving You Time.

Copyright © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Close

MDedge Home
Diseases & Conditions
- Depression
- Diabetes
- Hepatitis
- HIV
- Long COVID
- Obesity
- Pain
- PTSD
- Stroke
- Traumatic Brain Injury
Hematology and Oncology
Specialties
Federal News
Original Articles
- Case Reports
- Original Research
Reviews
- Best Practices
- Clinical Review
Perspectives
- Commentary
- Q&A
Diversity in Medicine

Explore

Multimedia
Explore
News
Explore
- News by Conference
Expert Interview
For Residents
Quizzes
Explore
- MD-IQ
CME Supplements
ReCAP
Conference ReCAP
Supplements
Sponsored Content
Explore
Research Summaries
Explore
- Clinical Edge Journal Scan
Roundtables
CE/CME
Submission Guidelines
Subscribe to Federal Practitioner
Treatment of Veterans With Metastatic Hormone-Sensitive Prostate Cancer

Medical Directors / Pharmacy Directors
Nurse Practitioners / Physician Assistants
Residents
VA / DoD / PHS

More

AVAHO Updates
Digital Edition/App